Symptom clusters among MsFLASH clinical trial participants-Reference-Cited by-同舟云学术

Symptom clusters among MsFLASH clinical trial participants

Published:2016-02 Issue:2 Volume:23 Page:158-165
ISSN:1072-3714
Container-title:Menopause
language:en
Short-container-title:

Author:

Woods Nancy Fugate,Hohensee Chancellor,Carpenter Janet S.,Cohen Lee,Ensrud Kristine,Freeman Ellen W.,Guthrie Katherine A.,Joffe Hadine,LaCroix Andrea Z.,Otte Julie L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynaecology

Reference37 articles.

1. Symptom clusters during the late reproductive stage through the early postmenopause: observations from the Seattle Midlife Womens Health Study.;Cray;Menopause,2012

2. Endocrine biomarkers and symptom clusters during the menopausal transition and early postmenopause: observations from the Seattle Midlife Womens Health Study.;Woods;Menopause,2014

3. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.;Freeman;J Am Med Assoc,2011

4. Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy menopausal women with hot flashes: a randomized controlled trial.;Ensrud;Menopause,2012

5. Effect of escitalopram on hot flash interference and daynight hot flashes: a randomized, controlled trial.;Carpenter;Fertil Steril,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause;JAMA;2024-08-22

2. A New Era in Menopause Management?;JAMA;2024-08-22

3. Sleep disturbance associated with the menopause;Menopause;2024-06-25

4. Elinzanetant, a new combined neurokinin-1/-3 receptor antagonist for the treatment of postmenopausal vasomotor symptoms;Expert Opinion on Pharmacotherapy;2024-05-02

5. Design of OASIS 1 and 2: phase 3 clinical trials assessing the efficacy and safety of elinzanetant for the treatment of vasomotor symptoms associated with menopause;Menopause;2024-04-03